Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
342
datasets available to search
ShareScore release 0.9.0
Dataset results
342 results for “biliary tract”
Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients
ClinicalTrials.gov study NCT02866383. IPD Sharing: NO. Countries: 1. Publications: 2.
ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers
ClinicalTrials.gov study NCT02351765. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT04642664. IPD Sharing: NO. Countries: 1. Publications: 11.
Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study
ClinicalTrials.gov study NCT00747097. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colore
ClinicalTrials.gov study NCT03929666. IPD Sharing: NO. Countries: 4. Publications: 1.
Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer
ClinicalTrials.gov study NCT04308174. IPD Sharing: NO. Countries: 1. Publications: 3.
Endoscopic Evaluation of Premalignant Lesions in the Biliary Tract and Pancreatic Ducts
ClinicalTrials.gov study NCT02057146. IPD Sharing: Not stated. Countries: 1. Publications: 3.
GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer
ClinicalTrials.gov study NCT02182778. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Sunitinib as Second-line Treatment in Advanced Biliary Tract Carcinoma
ClinicalTrials.gov study NCT01082809. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT01284413. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
ClinicalTrials.gov study NCT02170090. IPD Sharing: NO. Countries: 8. Publications: 1.
ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT07151118. IPD Sharing: NO. Countries: 1. Publications: 20.
CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence
ClinicalTrials.gov study NCT06037980. IPD Sharing: NO. Countries: 1. Publications: 4.
Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer
ClinicalTrials.gov study NCT03046862. IPD Sharing: NO. Countries: 1. Publications: 1.
Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT00073905. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen for the Treatment of Advanced Malignant Tumor of Biliary Tract
ClinicalTrials.gov study NCT02632019. IPD Sharing: Not stated. Countries: 1. Publications: 43.
Tislelizumab（Anti PD-1), Lenvatinib and GEMOX Transformation in the Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT05156788. IPD Sharing: NO. Countries: 1. Publications: 1.
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT04871321. IPD Sharing: NO. Countries: 1. Publications: 8.
Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT06893380. IPD Sharing: NO. Countries: 1. Publications: 10.
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT07146646. IPD Sharing: YES. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.